Perspectives on the Pharmacotherapy of Vertigo
- 1 September 1985
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 111 (9) , 609-612
- https://doi.org/10.1001/archotol.1985.00800110087009
Abstract
• Recent evidence from experiments in animals suggests a rationale for more effective pharmacologic and physical therapy in patients with vertigo. In particular, one must consider the possible effects of medications on the adaptive processes that naturally mediate recovery from vestibular lesions. The challenge now is for clinicians to devise medication and exercise regimens for patients with vestibular disturbances and critically (and quantitatively) evaluate their effects. (Arch Otolaryngol 1985;111:609-612)Keywords
This publication has 17 references indexed in Scilit:
- Pharmacology of the isolated semicircular canal: Effect of GABA and picrotoxinExperimental Brain Research, 1984
- Vestibular Compensation: An OverviewActa Oto-Laryngologica, 1983
- Suppressive action of picrotoxin, a gaba antagonist, On labyrinthine spontaneous nystagmus and vertigo in manActa Oto-Laryngologica, 1982
- Medikamentöse und physikalische Therapie des Schwindels und der Ataxie*Fortschritte der Neurologie · Psychiatrie, 1981
- Vestibular Compensation: New PerspectivesProceedings in Life Sciences, 1981
- Aspects of Vestibular Compensation in Guinea PigsProceedings in Life Sciences, 1981
- Vestibular pharmacologyTrends in Pharmacological Sciences, 1980
- Modifications and development of spinal reflexes in the alert baboon (Papio papio) following an unilateral vestibular neurotomyBrain Research, 1976
- Removal of vestibular commissural inhibition by antagonists of GABA and glycineBrain Research, 1973
- Droperidol and Fentanyl Citrate Compound as a Vestibular DepressantArchives of Otolaryngology (1960), 1969